An interventional study of "Embraceme" self-compassion intervention in Self-Compassion, sponsored by Hong Kong Metropolitan University. Not yet recruiting at 1 site in Hong Kong. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-09.
Sponsored by Hong Kong Metropolitan University · Not applicable, Interventional, and Treatment
This proposed pilot study aims to evaluate the "EmbraceMe", a self-compassion intervention to improve positive body image and mental health among transgender and gender-diverse (TGD) people in Hong Kong.
266 studies on the registry are indexed under Social Stigma; 66 are open to participants now.
This study's planned enrollment of 70 is below the median of 139 across 217 interventional studies indexed under Social Stigma.
Browse Social Stigma studies →Hong Kong Metropolitan University is the lead sponsor of 56 studies on the registry; 31 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in the "EmbraceMe" intervention group will receive group-based self-compassion intervention comprising five consecutive weekly sessions, with each session lasting 2 hours (totaling 10 hours).
Other: "Embraceme" self-compassion intervention
Participants in the waiting-list control group will receive the "EmbraceMe" intervention after thecompletion of the intervention at a 3-month follow-up.
Participants in the "EmbraceMe" intervention group will receive group-based self-compassion intervention comprising five consecutive weekly sessions, with each session lasting 2 hours (totaling 10 hours). Each session will include an introduction, guided exercises, group discussions and home practice.
Feasibility outcomes
Completion rate: In each group, the completion rate is defined as the number of participants who complete outcome measurements at immediate post-intervention and 3-month follow-up divided by those who are randomized.
Time frame: Baseline; immediately after the intervention; 3-month post-intervention.
Acceptability
The acceptability of the intervention will be assessed using a self-developed online acceptancequestionnaire. It consists of 10 items rated on a 5-point Likert scale (1 = very dissatisfied, 5 = very satisfied). Furthermore, semi-structured individual interviews will be conducted to explore the participants' experiences of the intervention.
Time frame: Immediately after the intervention
Self-compassion
Self-compassion will be measured using the short version of the self-compassion scale. It has 12 items. The total score ranges from 12 to 60, with higher scores indicating a higher level of self-compassion.
Time frame: Baseline; immediately after the intervention; 3-month post-intervention.
Internalized stigma
Internalized stigma will be measured by the Chinese version of the self-stigma scale. It has 9 items. The total score ranges from 9 to 36, with higher scores indicating a higher level of internalized stigma.
Time frame: Baseline; immediately after the intervention; 3-month post-intervention.
Self-esteem
Self-esteem will be assessed by the Rosenberg Self-esteem Scale (RES). It has 10 items. The total score ranges from 10 to 40, with higher scores indicating highlevels of self-esteem.
Time frame: Baseline; immediately after the intervention; 3-month post-intervention.
Body appreciation
Body appreciation will be measured by the body appreciation scale (BAS-2). It has 10 items. The total score ranges from 5 to 50, with higher scores representing a higher level of body appreciation.
Time frame: Baseline; immediately after the intervention; 3-month post-intervention.
Anxiety
Anxiety symptoms will be screened using the Generalized Anxiety Disorder Scale(GAD-7). It has 7 items. The total score ranges from 0 to 21, with higher scores representing a higher level of anxiety.
Time frame: Baseline; immediately after the intervention; 3-month post-intervention.
Depression
Depression will be measured using the 9-item Patient HealthQuestionnaire (PHQ-9). It has nine items. The total score ranges from 0 to 27, with higher scores indicating a higher level of depression.
Time frame: Baseline; immediately after the intervention; 3-month post-intervention.
Plan to share: No — Due to the sensitive nature of the participant population (transgender and gender-diverse individuals), we will only share the individual participant data (IPD) that directly underpin the results presented in the publication.
No publications or documents are linked to this record.
Start is estimated for Nov 2026; primary completion for Apr 2028, 17 months later.
Of 162 non-industry interventional studies with no phase under Social Stigma, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 32. This study's planned 17 months is above that.
Counting every sponsor, half of 164 studies reached it within 15 months; a quarter within 5 and three quarters within 32.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hong Kong Metropolitan University